Cargando…

Stall in Heart Disease Death Rates, Evidence From Maine, 1999–2017

INTRODUCTION: Since the 1950s, heart disease deaths have declined in the United States, but recent reports indicate a plateau in this decline. Heart disease death rates increased in Maine from 2011–2015. We examined reasons for the trend change in Maine’s heart disease death rates, including the con...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinatra, Jennifer A., Huston, Sara L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458105/
https://www.ncbi.nlm.nih.gov/pubmed/32816665
http://dx.doi.org/10.5888/pcd17.190405
_version_ 1783576128204570624
author Sinatra, Jennifer A.
Huston, Sara L.
author_facet Sinatra, Jennifer A.
Huston, Sara L.
author_sort Sinatra, Jennifer A.
collection PubMed
description INTRODUCTION: Since the 1950s, heart disease deaths have declined in the United States, but recent reports indicate a plateau in this decline. Heart disease death rates increased in Maine from 2011–2015. We examined reasons for the trend change in Maine’s heart disease death rates, including the contributing types of heart disease. METHODS: We obtained Maine’s annual heart disease death data for 1999–2017 from CDC’s Wide-ranging Online Data for Epidemiologic Research (CDC WONDER). We used joinpoint regression to determine changes in trend and annual percentage change (APC) in death rates for heart disease overall and by demographic groups, types of heart disease, and geographic area. RESULTS: Joinpoint modeling showed that Maine’s age-adjusted heart disease death rates decreased during 1999–2010 (−4.2% APC), then plateaued during 2010–2017 (−0.1% APC). Death rates flattened for both sexes and age groups ≥45 years. Although death rates for acute myocardial infarction (AMI) decreased through 2017, hypertensive heart disease (HHD) and heart failure death rates increased. Death rates attributable to diabetes-related heart disease and non-AMI ischemic heart disease (IHD) plateaued. CONCLUSION: Declines in Maine’s heart disease death rates have plateaued, similar to national trends. Flattening rates appear to be driven by adverse trends in HHD, heart failure, diabetes-related heart disease, and non-AMI IHD. Increased efforts to address cardiovascular disease risk factors, chronic heart disease, and access to care are necessary to continue the decrease in heart disease deaths in Maine.
format Online
Article
Text
id pubmed-7458105
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-74581052020-09-04 Stall in Heart Disease Death Rates, Evidence From Maine, 1999–2017 Sinatra, Jennifer A. Huston, Sara L. Prev Chronic Dis Original Research INTRODUCTION: Since the 1950s, heart disease deaths have declined in the United States, but recent reports indicate a plateau in this decline. Heart disease death rates increased in Maine from 2011–2015. We examined reasons for the trend change in Maine’s heart disease death rates, including the contributing types of heart disease. METHODS: We obtained Maine’s annual heart disease death data for 1999–2017 from CDC’s Wide-ranging Online Data for Epidemiologic Research (CDC WONDER). We used joinpoint regression to determine changes in trend and annual percentage change (APC) in death rates for heart disease overall and by demographic groups, types of heart disease, and geographic area. RESULTS: Joinpoint modeling showed that Maine’s age-adjusted heart disease death rates decreased during 1999–2010 (−4.2% APC), then plateaued during 2010–2017 (−0.1% APC). Death rates flattened for both sexes and age groups ≥45 years. Although death rates for acute myocardial infarction (AMI) decreased through 2017, hypertensive heart disease (HHD) and heart failure death rates increased. Death rates attributable to diabetes-related heart disease and non-AMI ischemic heart disease (IHD) plateaued. CONCLUSION: Declines in Maine’s heart disease death rates have plateaued, similar to national trends. Flattening rates appear to be driven by adverse trends in HHD, heart failure, diabetes-related heart disease, and non-AMI IHD. Increased efforts to address cardiovascular disease risk factors, chronic heart disease, and access to care are necessary to continue the decrease in heart disease deaths in Maine. Centers for Disease Control and Prevention 2020-08-20 /pmc/articles/PMC7458105/ /pubmed/32816665 http://dx.doi.org/10.5888/pcd17.190405 Text en https://creativecommons.org/licenses/by/4.0/Preventing Chronic Disease is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Original Research
Sinatra, Jennifer A.
Huston, Sara L.
Stall in Heart Disease Death Rates, Evidence From Maine, 1999–2017
title Stall in Heart Disease Death Rates, Evidence From Maine, 1999–2017
title_full Stall in Heart Disease Death Rates, Evidence From Maine, 1999–2017
title_fullStr Stall in Heart Disease Death Rates, Evidence From Maine, 1999–2017
title_full_unstemmed Stall in Heart Disease Death Rates, Evidence From Maine, 1999–2017
title_short Stall in Heart Disease Death Rates, Evidence From Maine, 1999–2017
title_sort stall in heart disease death rates, evidence from maine, 1999–2017
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458105/
https://www.ncbi.nlm.nih.gov/pubmed/32816665
http://dx.doi.org/10.5888/pcd17.190405
work_keys_str_mv AT sinatrajennifera stallinheartdiseasedeathratesevidencefrommaine19992017
AT hustonsaral stallinheartdiseasedeathratesevidencefrommaine19992017